In the Lancet Journal the first full peer reviewed efficacy results got published for the COVID-19 vaccine AstraZeneca which was developed together by Oxford University and British Swedish pharmaceutical company. The interim results from the clinical trials revealed that it is 70 percent effective against symptomatic disease. Although Moderna claims 94% efficiency and Pfizer has already been granted the emergency approval for the usage of vaccine in UK, no one is listed in any journal.
